Animal studies have shown that ALCAR supplementation can improve the synaptic plasticity of mammalian neural tissue and improve learning
some data indicates up to 15% of users experience shedding on GLP-1s
GLP-1RAs represent a promising new strategy for patients with psychiatric disorders, offering the possibility of meaningful weight loss while also improving metabolic health changes that can significantly enhance quality of life. They undertook a systematic review and meta-analysis of ultimately nine RCTs to assess the efficacy and safety of GLP-1 RAs in individuals with psychiatric disorders (specifically, schizophrenia or schizoaffective disorder, bipolar disorder, psychosis, major depressive disorder, binge-eating disorder, or a combination) and obesity/overweight, focusing on weight and metabolic outcomes
Swallowed as a pill, your digestive system destroys about 99.2% before it can be absorbed only 0.8% gets used
As an estimate, over 3 million citizens have known diabetes in Italy [12]